N-asetil sistein: İlaca bağlı akut pankreatitte de kullanılabilecek bir tedavi seçeneği mi?

Yıl 2017, Cilt: 7 Sayı: 4, 385 - 390, 13.12.2017

Osman Bülent Zülfikar , Halil Haldun Emiroğlu

https://doi.org/10.16899/gopctd.358803

Öz

Amaç: Akut pankreatit etiyolojisinde ilaçlar
nispeten seyrek bir nedendir. Çalışmamızda ilaç kullanımına bağlı akut
pankreatit gelişen ve N-asetilsistein tedavisi sonrası iyileşen 6 hastanın
retrospektif değerlendirmesini amaçlanmıştır.

Gereç ve Yöntem: 2007-2017
yılları arasında ilaca bağlı akut pankreatit tanısı alan ve NAC tedavisi
uygulanan 6 çocuk hastanın dosyaları retrospektif olarak incelendi. Altı
hastanın akut pankreatit tanısı "Uluslararası Çocuk Pankreatit Çalışma
Grubu" tarafından önerilen kriterlere göre konuldu. Hastalığın şiddet
derecesi NASPGHAN kriterlerine göre belirlendi.  

Bulgular: Akut pankreatit tedavisi sırasında
NAC uygulanan ilaca bağlı akut pankreatitli 6 hastanın tümü tamamen iyileşti.

Sonuç: NAC, ilaca bağlı akut pankreatit
tedavisi için faydalı görünmektedir.

Anahtar Kelimeler

Pankreatit, N-asetil sistein

N-acetyl cysteine: Is it an option for treatment of drug induced acute pancreatitis?

Öz

Abstract

Aim: Drugs are a
relatively rare cause of acute pancreatitis. We aimed a retrospective
evaluation of 6 patients with drug induced acute pancreatitis, who were
recovered after N-acetyl cysteine treatment.

Materials
and Methods: .  The information in the
files of 6 patients with drug induced acute pancreatitis who were improved
after NAC treatment  between 2007 and
2017 was retrospectively reviewed. The criteria recommended by the
International Study Group of Pediatric Pancreatitis were used for the diagnosis
of acute pancreatitis in 6 patients. The severity of the disease was determined
according to NASPGHAN criteria

Results: All of the 6
patients with drug induced acute pancreatitis who underwent NAC during the
treatment of acute pancreatitis were completely healed.

Conclusion: NAC treatment
seems to be beneficial for drug induced acute pancreatitis.

Anahtar Kelimeler

Panceatitis, N-acetyl cysteine

Kaynakça

• 1. Johnson K, McEvoy CE, Naqvi S, et al. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis 2016;11:799-807. 2. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;20(10):1058–63. 3. Bucaretchi F, Fernandes CB, Branco MM, et al. Acute liver failure in a term neonate after repeated paracetamol administration. Rev Paul Pediatr 2014;32(1):144-8. 4. Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006;44(1):1–18. 5. Mumtaz K, Azam Z, Hamid S, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009; 3(4): 563-70. 6. Hu J, Zhang Q, Ren X, Sun Z, Quan Q. Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials. Clin Res Hepatol Gastroenterol 2015; 39(5):594-9. 7. Saleem AF, Abbas Q, Haque AU. Use of N-acetylcysteine in children with fulminant hepatic failure caused by acuteviral hepatitis. J Coll Physicians Surg Pak. 2015; 25(5):354-8. 8. Schlang HA. Acetylcysteine in the removal of a bezoar. JAMA 1970;214(7):1329. 9. Rescola FJ, Grosfeld JL, West KJ, Vane DW. Changing patterns of treatment and survival in neonates with meconium ileus. Arch Surg 1989;124(7):837–40. 10. Lowe ME. Pancreatitis. In: Wyllie R, Hyams JS, Kay M, eds. 5th ed. Pediatric Gastrointestinal and Liver Disease. Philadelphia: Elsevier; 2016. p.1016-26. 11. Sevillano S, De la Mano AM, De Dios I, Ramudo L, Manso MA. Major pathological mechanisms of acute pancreatitis are prevented by N-acetylcysteine. Digestion 2003;68(1):34-40. 12. Sevillano S, De Dios I, De la Mano AM, Manso MA. N-acetylcysteine induces beneficial changes in the acinar cell cycle progression in the course of acute pancreatitis. Cell Prolif 2003;36(5):279-89. 13. Sateesh J, Bhardwaj P, Singh N, Saraya A. Effect of antioxidant therapy on hospital stay and complications in patients with early acute pancreatitis: a randomised controlled trial. Trop Gastroenterol 2009;30(4):201-6. 14. Morinville VD, Husain SZ, Bai H, et al. Definitions of pediatric pancreatitis and survey of current clinical practices: report from Insppire (International Study Group Of Pediatric Pancreatitis: In Search For A Cure). J Pediatr Gastroenterol Nutr 2012; 55(3): 261-5. 15. Abu-El-Haija M, Kumar S, Szabo F, Werlin S, Conwell D, Banks P, et al. Classification of acute pancreatits in the pediatric population: Clinical report from the NASPGHAN pancreas committee. J Pediatr Gastroenterol Nutr 2017;64(6): 984–990 16. Badalov N, Baradarian R, Kadirawel I, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5(6): 648-61. 17. Wu SF, Chen AC, Peng CT, Wu KH. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51(6): 824-5. 18. Suzuki M, Takata O, Sakaguchi S, Fujimura J, Saito M, Shimizu T. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis. Exp Hematol 2008; 36(3): 253-4. 19. Suzuki M, Sai JK, Shimizu T. Acute pancreatitis in children and adolescents. World J Gastrointest Pathophysiol 2014; 5(4): 416-26 20. Wang R, Yang F, Wu H, et al. High-dose versus low-dose octreotide in the treatment of acute pancreatitis: a randomized controlled trial. Peptides 2013; 40: 57-64. 21. Mumcu S, Alhan E, Türkyilmaz S, Kural BV, Erçin C, Kalyoncu NI. Effects of N-acetylcysteine on acute necrotizing pancreatitis in rats. Eur Surg Res 2005; 37(3): 173-8. 22. Eşrefoğlu M, Gül M, Ates B, Batçioğlu K, Selimoğlu MA. Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol 2006;12(2): 259-64.